tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Nihon Kohden Ends Abbott Partnership to Focus on In-House Growth

Story Highlights
Nihon Kohden Ends Abbott Partnership to Focus on In-House Growth

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Nihon Kohden Corporation ( (JP:6849) ) just unveiled an announcement.

Nihon Kohden Corporation has announced the termination of its distribution partnership with Abbott Medical Japan LLC, effective December 31, 2026. This decision aligns with Nihon Kohden’s strategy to transform its business portfolio and focus on its own products, aiming for long-term growth in the domestic market. The transition will be phased to ensure minimal disruption to patients and medical institutions, with the impact on financial results expected to be minor.

The most recent analyst rating on (JP:6849) stock is a Buy with a Yen1898.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.

More about Nihon Kohden Corporation

Nihon Kohden Corporation operates in the medical electronic equipment industry, focusing on the development and provision of medical devices and solutions. The company is known for its in-house products, consumables, and services, and aims to strengthen its presence in growth areas such as ventilators and digital health solutions.

Average Trading Volume: 506,059

Technical Sentiment Signal: Hold

Current Market Cap: Yen284.1B

See more insights into 6849 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1